))
Chart Review and Exploration of Achieving Remission in Major Depressive Disorder
Tandakan semua sebagai (belum) dimainkan
Siri yang diarkibkan ("Suapan tidak aktif" status)
When?
This feed was archived on May 12, 2019 01:08 (
Why? Suapan tidak aktif status. Pelayan kami tidak dapat untuk mendapatkan kembali suapan podcast yang sah untuk tempoh yang didapati.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage series 1155732
Kandungan disediakan oleh CME Outfitters and LLC. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh CME Outfitters and LLC atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
For patients with major depressive disorder (MDD), achieving remission is the penultimate therapeutic goal. Yet as many as two-thirds of patients do not achieve remission after initial treatment with a first-line antidepressant.(1) This neuroscienceCME Chart Review activity addresses clinician-based gaps that may contribute to underachievement of sustained remission in patients with MDD. Specifically, an index patient case will be used as the content foundation upon which expert faculty will engage in a provocative, consult-type exchange.
…
continue reading
1 episod
Kongsi
